Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04152863
Title Efficacy, Safety, and Tolerability of V937 Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NOR | ITA | ISR | FRA | ESP | DEU | AUS

Facility Status City State Zip Country Details
Henry Ford Hospital ( Site 0008) Detroit Michigan 48202 United States Details
Rutgers Cancer Institute of New Jersey ( Site 0002) New Brunswick New Jersey 08903 United States Details
Providence Portland Medical Center [Portland, OR] ( Site 0005) Portland Oregon 97213 United States Details
Northwest Medical Specialties, PLLC ( Site 0006) Tacoma Washington 98405 United States Details
The Queen Elizabeth Hospital ( Site 0143) Woodville South Australia 5011 Australia Details
Alfred Health ( Site 0142) Melbourne Victoria 3004 Australia Details
Fiona Stanley Hospital ( Site 0141) Murdoch Western Australia 6150 Australia Details
FALP-UIDO ( Site 2062) Santiago Region M. De Santiago 6900941 Chile Details
Bradfordhill-Clinical Area ( Site 2061) Santiago Region M. De Santiago 8420383 Chile Details
Centre Georges Francois Leclerc ( Site 2025) Dijon Cote-d Or 21079 France Details
CHU de Grenoble Hopital Nord ( Site 2027) La Tronche Isere 38700 France Details
Universitaetsklinikum Tuebingen-Hautklinik ( Site 2001) Tübingen Baden-Wurttemberg 72076 Germany Details
Universitaetsklinikum Regensburg ( Site 2007) Regensburg Bayern 93053 Germany Details
Universitaetsklinikum Leipzig AOeR ( Site 2005) Leipzig Sachsen 04103 Germany Details
Rambam Health Care Campus-Oncology Division ( Site 0040) Haifa 3109601 Israel Details
Hadassah Ein Kerem Medical Center ( Site 0042) Jerusalem 9112001 Israel Details
Chaim Sheba Medical Center ( Site 0041) Ramat Gan 5262000 Israel Details
Istituto Europeo di Oncologia ( Site 2040) Milano 20141 Italy Details
Policlinico Le Scotte - A.O. Senese ( Site 2039) Siena 53100 Italy Details
Seoul National University Hospital ( Site 1992) Seoul 03080 Korea, Republic of Details
Severance Hospital Yonsei University Health System ( Site 1993) Seoul 03722 Korea, Republic of Details
Oslo Universitetssykehus Radiumhospitalet ( Site 0060) Oslo 0424 Norway Details
WITS Clinical Research CMJAH Clinical Trial Site ( Site 0101) Johannesburg Gauteng 2193 South Africa Details
Clinical Research Unit - University of Pretoria ( Site 0102) Pretoria Gauteng 0002 South Africa Details
Wilgers Oncology Centre ( Site 0103) Pretoria Gauteng 0081 South Africa Details
Little Company of Mary Hospital ( Site 0100) Pretoria Gauteng 0181 South Africa Details
Cape Town Oncology Trials Pty Ltd ( Site 0104) Cape Town Western Cape 7570 South Africa Details
Onkologikoa - Instituto Oncologico de San Sebastian ( Site 0088) San Sebastian Gipuzkoa 20014 Spain Details
Clinica Universitaria de Navarra. ( Site 0082) Pamplona Navarra 31008 Spain Details
Hospital Clinico Universitario de Valencia ( Site 0090) Valencia Valenciana, Comunitat 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field